GSK (GSK LN)

143

Analysis

Health Care • United Kingdom

GSK is a British multinational biopharmaceutical company focused on the research, development, and delivery of innovative vaccines and specialty medicines. It addresses major disease areas including HIV, respiratory, oncology, and infectious diseases. The company was established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, and is headquartered in London, England.

Refresh

Exchange Announcement • 14 Oct 2026 21:30

Director/PDMR Shareholding

Exchange Announcement • 13 Oct 2026 21:30

Director/PDMR Shareholding

Exchange Announcement • 12 Oct 2026 21:30

Director/PDMR Shareholding

Exchange Announcement • 08 Oct 2026 21:00

Wendy Becker CBE - New Directorship

Exchange Announcement • 06 Oct 2026 21:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Director/PDMR Shareholding

Director/PDMR Shareholding

Director/PDMR Shareholding

Wendy Becker CBE - New Directorship

Admission to Trading